Director-affiliated fund sells $127.4M in Cogent Biosciences stock
summarizeSummary
Fairmount Funds Management LLC, an entity affiliated with a director, executed a substantial open market sale of Cogent Biosciences stock totaling $127.4 million. This significant disposition, representing over 2% of the company's market capitalization, could signal a reduction in conviction from a key institutional investor and director-affiliated entity. The shares were sold at $36.40, below the current market price of $39.53. Investors should monitor for further insider activity or any related company announcements.
check_boxKey Events
-
Significant Insider Sale
Fairmount Funds Management LLC, an entity affiliated with a director, sold 3,500,000 shares of Cogent Biosciences common stock for a total value of $127,400,000.
-
Substantial Stake Reduction
The sale represents a significant portion of the company's market capitalization and reduces the reporting owner's common stock holdings to 5,503,418 shares post-transaction.
-
Transaction Details
The shares were sold at a price of $36.40 per share on January 22, 2026, which is below the current stock price of $39.53.
auto_awesomeAnalysis
Fairmount Funds Management LLC, an entity affiliated with a director, executed a substantial open market sale of Cogent Biosciences stock totaling $127.4 million. This significant disposition, representing over 2% of the company's market capitalization, could signal a reduction in conviction from a key institutional investor and director-affiliated entity. The shares were sold at $36.40, below the current market price of $39.53. Investors should monitor for further insider activity or any related company announcements.
在该文件披露时，COGT的交易价格为$39.53，交易所为NASDAQ，所属行业为Life Sciences，市值约为$60.1亿。 52周交易区间为$3.72至$43.73。 这份文件被评估为消极市场情绪，重要性评分为9/10。